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Abstract 
Review on ATP2B4, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: ATP2B2, MXRA1, PMCA4, 
PMCA4b, PMCA4x 
HGNC (Hugo): ATP2B4 
Location: 1q32.1 
DNA/RNA 
Description 
The human ATP2B4 gene (ATPase, Ca++ 
transporting, plasma membrane 4) is coding subunit 
of plasma membrane Ca2+ ATPase (PMCA). The 
ATP2B4 gene is located on the plus strand and spans 
117295 bps of genomic region (203626787 - 
203744081). There are 22 exons and 2 transcript 
variants for ATP2B4 gene (figure 1). The size of 
transcript variant 1 and transcript variant 2 is 8920 nt 
and 8742 nt, respectively.  
Figure 1. Location of ATP2B4 gene and representation of its transcripts. ATP2B4 is localized on chromosome 1q32.1 and 
consists of 2 transcript variant. Small RNA gene SNORA77, non-coding RNA LINC00260 and pseudogene LOC100421749 are 
encoded in this region. 
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Figure 2. Figure showing different domains of ATP2B4 protein. Plasma-membrane calcium-translocating P-type ATPase (orange 
colored), E1-E2 ATPase (green colored), HAD_like (red coloures), cation transporting ATPase, C-terminus (purple coloured). 
 
Transcript variant 1 represents the longer transcript 
and encodes the shorter isoform (4a). Plasma 
membrane calcium-transporting ATPase 4 isoform 
4a (accession number NP_001001396.1) protein 
product comprise of 1170 amino acids (aa). Plasma 
membrane calcium-transporting ATPase 4 isoform 
4b (accession number NP_001675.3) products of 
transcript variant 2 comprise of 1205 aa. 
Transcription 
ATP2B4 gene has 2 transcript variants. But Ensembl 
database shows 7 transcripts (splice variants). 
ATP2B4 mRNA transcript variant 1 (accession 
number NM_001001396.2) includes 22 exons and 
total annotated spliced exon length is 8920. It has 21 
coding exons. Transcript variant 2 (accession 
number NM_001684.4) has 21 exons and 20 coding 
exons. It has total annotated spliced exon length 
8742 (figure 1). ATP2B4 gene has an important role 
in maintaining intracellular calcium balance as it is 
involved in taking the calcium ions out of the cells. 
The extreme elevation of ATP2B4 gene expression 
during the differentiation of cells in colon cancer is 
thought to be associated with the calcium stream. 
Though not very clear with evidences, changes in 
expression levels of PMCA gene is shown as a 
distinctive feature of some colon cancer (Aung et al., 
2007). An increase the expression of the ATP2B4 
gene has been found in colorectal tumor patients 
(Geyik et al., 2014). 
A pseudogene LOC100421749 is encoded in the 
intronic region of the ATP2B4 gene. At the same 
time, long intergenic non-protein coding RNA 260 
(LINC00260), LOC102723543 and small nucleolar 
RNA, H/ACA box 77 (SNORA77) are also encoded 
by this gene. LINC00260 and SNORA77 are 
encoded in the same strand while LOC100421749 
and LOC102723543 are encoded in the opposite 
strands (figure 1). 
Pseudogene 
There is no known pseudogene for ATP2B4. 
Protein 
Description 
ATP2B4 protein is among one of the isoform of 
plasma membrane Ca2 + ATPase (PMCA). 4a and 
4b are the two isoforms of this protein. Plasma 
membrane calcium-transporting ATPase 4 isoform 
4a is encoded by transcript variant 1 and comprise of 
1170 aa. Its molecular weight is 129.4 kDa with an 
isoelectric point of 7.4995. Plasma membrane 
calcium-transporting ATPase 4 isoform 4b 
comprising of 1205 aa is encoded by transcript 
variant 2. The molecular weight of this isoform is 
about 134 kDa and its isoelectric point is 6.3516. 
Different regions like ATP2B4 protein, cation 
transporter/ATPase, N-terminus, plasma-membrane 
calcium-translocating P-type ATPase, E1-E2 
ATPase, haloacid dehalogenase-like hydrolases; 
HAD_like domain, Putative hydrolase of sodium-
potassium ATPase alpha subunit; HAD_like II 
domain and cation transporting ATPase, C-terminus 
are formed from plasma membrane calcium 
transporter ATPase C terminal domain (figure 2). 
Isoform 4a includes both calmodulin binding 
subdomain A and calmodulin binding subdomain B. 
But isoform 4b does not include these domains 
(figure 2). 
Calcium ions are involved in the regulation of 
several cellular processes, including activation or 
inactivation of the cellular signaling pathways like 
calcium regulatory proteins (Berridge et al., 2003). 
Active transport of calcium ions in the plasma 
membrane which requires ATP hydrolysis is 
achieved through calcium pump (Monteith et al., 
2007). P-type ATPase is responsible for 
translocating the extracellular calcium ions in 
eukaryotes. There are several isoforms of PMCA in 
human and mouse but without any additional 
functions. There are many diseases in humans which 
are supposed to be caused by errors in PMCA.  
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Figure3. Figure showing cytoplasmic region of plasma membrane of ATP2B4 protein. Localization of transmembranes and 
extracellular regions are shown. Ten transmembrane domains are also cited. 
 
P-type ATPase in the plasma membrane calcium 
ATPase (PMCA) plays an important role in 
determining the amount of intracellular calcium 
(Jensen et al., 2004). Both N and C terminal of the 
calcium pump are located inside cells and contain 10 
transmembrane regions. The C terminal is typically 
70-200 aa in length and is considered to take part in 
the regulation of the calcium pump. Furthermore 
calcium ions are also responsible for stimulating 
tasks inside cells and this stimulus is generally 
provided by the calmodulin residing in the C 
terminal. Calmodulin is a calcium binding protein 
and is activated by its binding to calcium. Moreover, 
there are 4 isoforms and more than 30 alternative 
variants known for PMCA (Strehler and Zacharias, 
2001). PMCA1 (ATP2B1) and PMCA4 (ATP2B4) 
were found in many cell types while PMCA2 
(ATP2B2) and PMCA3 (ATP2B3) is reported to 
exist in different tissues (Carafoli, 1991; Strehler and 
Zacharias, 2001). 
Expression 
The expression of ATP2B4 protein varies according 
to the type of cancer. For example; ATP2B4 was 
found to be upregulated in the breast cancer cell lines 
(Varga et al., 2014). An increase the protein levels of 
ATP2B4 have been reported in the gastric cancer cell 
line (KATO-III) (Ribiczey et al., 2007). In another 
study with colon cancer, ATP2B4 protein expression 
from PMCA was found to be upregulated (Aung et 
al., 2007). 
Localisation 
ATP2B4 protein is localized in the plasma 
membrane. There are 10 transmembrane domains of 
this protein (figure 3). Cytoplasmic region, 
transmembrane region and extracellular regions of 
ATP2B4 are shown in figure 3. 
Function 
As shown in the structural form as well, ATP2B4 
protein has role in the ATP binding as well as 
calmodulin binding activities. Calmodulin gets 
activated after binding to calcium ions and 
eventually activates the stimulating tasks of these 
ions. ATP2B4 is located in the tail of the C-terminal 
end (Brini et al., 2013). 
Plasma membrane Ca2 + ATPases are dependent on 
ATP and are involved in the removal of calcium 
from the cell and thus are classified as transporter 
proteins in plasma membrane. These proteins have 
an important role in determining the amount of 
intracellular calcium (Jensen et al., 2004). The short 
term increase of intracellular Ca2+ in specific 
locations play a major role in muscle contraction and 
stimulus transduction pathways (Monteith et al., 
2007; Roberts-Thomson et al., 2010). 
Acidic phospholipids particularly 
polyphosphoinositides are strong stimulants of 
PMCA. As PMCA isoforms increase the access of 
phospholipids to acidic phospholipid binding sites, it 
effects the regulation of phospholipids (Strehler and 
Zacharias, 2001). 
In a study related to ATP2B4 protein, it has been 
found that several members of MAGUK 
(membrane-associated guanylate kinase) protein 
show high interaction with PZD domains. This 
interaction was shown to take place due to the C 
terminal sequence (Kim et al., 1998). In another 
study, interaction of ATP2B4 with NOS-II has been 
shown in HEK293 cells. The interaction of NOS-I 
with PZD domain has also been shown (Schuh et al., 
2001). The dose dependent inactivation of NOS-I 
has been shown to be mediated by ATP2B4 (Schuh 
et al., 2001). 
ATP2B4 protein was found to be expressed in heart 
(Strehler and Zacharias, 2001). An interaction of 
nNOS with ATP2B4 proteins have been shown in 
cardiomyocytes. It also has been found to be 
overexpressed in cardiomyocytes (Williams et al., 
2006). 
ATP2B4 protein has two isoforms i.e 4a and 4b. 4b 
isoform showed low basal activity in the absence of 
calmodulin. This isoform is also slowly activated by 
Ca2+-calmodulin complex. The calmodulin-
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activated pump is slowly inactivated in 4b isoform 
(Caride et al., 2001a; Caride et al., 2001b; Penheiter 
et al., 2002). 
The full PMCA4b isoform as well as the C-
terminally truncated PMCA4a splice variant is coded 
by PMCA4. Biochemically, PMCA4b has several 
distinguishing features: first, it shows low basal 
activity when there is no calmodulin; second, it gets 
slowly activated by the Ca2+-calmodulin complex; 
and third it slowly inactivates the calmodulin-
activated pump (Caride et al., 2001a; Caride et al., 
2001b; Penheiter et al., 2002). 
Homology 
ATP2B4 gene and domains of its protein have been 
found to be partially conserved in some animals. For 
example, the DNA sequence in P. troglodytes shows 
99.6% similarity to humans and protein shows 
99.9% similarity, the DNA sequence in M.musculus 
shows 84.1% similarity and protein shows 84.1% 
similarity. In S. pombe (ATP2B4 gene name; 
SPAPB2B4.04c), there is 50% DNA similarity and 
44.8% protein similarity (data from NCBI BLAST). 
Mutations 
Somatic 
6 somatic mutations have been identified in ATP2B4 
gene.  
1- NM_001001396.2(ATP2B4):c.-464-21082A>G: 
there is conversion of A>G at the region located 
203661660 (GRCh38) of ATP2B4 gene. This 
mutation has been associated with lung cancer.  
2- NM_001001396.2(ATP2B4):c.2027C>T 
(p.Pro676Leu): a missense mutation has been 
identified at the region located 203711104 of this 
gene. There is transformation of proline to leucine 
with conversion of C>T at 676 position. It is 
associated with malignant melanoma.  
3- NM_001001396.2(ATP2B4):c.466C>T 
(p.Leu156Phe): a missense mutation has been 
identified at the region located 203699534 of this 
gene. There is transformation of leucine to 
phenylalanine at position 156 with conversion of 
C>T at 466 position. It is also associated with 
malignant melanoma.  
4- NM_001001396.2(ATP2B4):c.760C>T 
(p.Pro254Ser): a missense mutation has been 
identified at the region located 203700316 of this 
gene. It is associated with malignant melanoma. 
There is transformation of proline to serine with 
conversion of C>T at 760 position.  
5- NM_001001396.2(ATP2B4):c.2799C>T 
(p.Ile933=): there is no change in the amino acid 
sequence with C>T transformation at region located 
at 203721397. Isoleucine remains isoleucine even 
after C>T transformation at 933 position. This type 
of mutation is termed as synonymous or silent 
mutations. 
6- GRCh38/hg38 1q31.1-42.11(chr1:187143981-
224299417)x3: this mutation location is 
Chr1:187143981 - 224299417 (on Assembly 
GRCh38). Copy number gain variant has been found 
at a cytogenetic location 1q31-42.1 (Kaminsky et al., 
2011). ATP2B4 gene is also localized at this region. 
It belongs to pathogenic allele class. 
Implicated in 
Colorectal cancer 
Prognosis 
ATP2B4 mRNA levels have been shown to reduce 
in a significant way in adenocarcinoma and benign 
colon tumors as compared to normal colon tissue. In 
spite of increased ATP2B4 expression levels in 
differentiated colon cancer cells, decreased 
expression of levels of ATP2B4 in some colon 
cancers supports it to be their characteristic feature 
(Roberts-Thomson et al., 2010). In our previous 
study involving normal and tumor tissues of 
colorectal cancer patients, increased expression of 
ATP2B4 has been shown. Furthermore, ATP2B4 
mRNA level in rectal cancer patients was found to 
be significantly increased when they were separately 
studied (Geyik et al., 2014). It is believed that 
ATP2B4 plays an important and specific role 
tumorigenesis of colon cells and colon cancer (Aung 
et al., 2007; Aung et al., 2009). 
Gastric cancer 
Prognosis 
KATO-III, a gastric cancer cell line was treated with 
short chain fatty acids (SCFAs), Na+-valerate or 
Na+-butyrate. Na+-valerate and Na+-butyrate are 
well known differentiating agents and butyrate are 
physiologically located in the intestinal lumen 
(Ribiczey et al., 2007). ATP2B4 was found to be 
upregulated in KATO III cancer cell line after 
treatment with SCFAs. Both mRNA and protein 
level of ATP2B4 was to be significantly increased in 
gastric cancer cell line (Ribiczey et al., 2007). 
Breast cancer 
Prognosis 
ATP2B4 was found to be overexpressed in breast 
cancer. The expression level of ATP2B4 was studied 
in some breast cancer cell lines like MCF-7, MDA-
MB-231, and MCF-10A according to their 
confluence and subconfluence states. However, a 
significant difference was not found (Lee et al., 
2005). However, ATP2B4 mRNA level was found 
to be significantly lower in tumorigenic cell lines 
(ZR-75-1, T-47D, BT-483, and SK-BR-3) as 
compared to non-tumorigenic breast epithelial cell 
lines (184A1 and 184B5) (Lee et al., 2005). The 
breast cancer cell MCF-7 cells were treated with 
SCFAs like butyrate, phenylbutyrate, and valerate. 
ATP2B4 protein level was found to increase after 
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this treatment. The remodeling of Ca2 + homeostasis 
in cancer cells is a distinguishing feature of tumor 
progression and the role of ATP2B4 during this 
process has been supported by many studies (Varga 
et al., 2014). 
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